Max Greenberg

Three subtypes of lung cancer fibroblasts define distinct therapeutic paradigms.

M. Mino‐Kenudson, L. Sequist, J. Engelman, 2021, Cancer cell.

Targeting FGFR overcomes EMT-mediated resistance in EGFR mutant non-small cell lung cancer

Joshua M. Korn, J. Korn, P. Hammerman, 2019, Oncogene.

Primary Patient-Derived Cancer Cells and Their Potential for Personalized Cancer Patient Care

L. Sequist, A. Dastur, J. Engelman, 2017, Cell reports.

PD-L1 expression and CD8+ infiltration shows heterogeneity in juvenile recurrent respiratory papillomatosis.

M. Mino‐Kenudson, J. Engelman, C. Benes, 2017, International Journal of Pediatric Otorhinolaryngology.

NOTCH1 Represses MCL-1 Levels in GSI-resistant T-ALL, Making them Susceptible to ABT-263

U. McDermott, M. Garnett, A. Dastur, 2018, Clinical Cancer Research.

KRAS G12C NSCLC Models Are Sensitive to Direct Targeting of KRAS in Combination with PI3K Inhibition

P. Zarrinkar, Patricia Greninger, C. Benes, 2018, Clinical Cancer Research.